Nanoparticle therapy restores light sensitivity in blind retinas

A multinational research consortium has announced a breakthrough that could restore vision for people with retinal blindness. The team has engineered microscopic particles that act as artificial light receptors, enabling damaged retinas to respond to illumination.

The particles are delivered via injection into the eye, where they settle adjacent to the retinal ganglion cells that normally transmit visual information to the brain. When light strikes the particles, they generate electrical and chemical signals that activate the nearby nerve cells. This activation prompts the ganglion cells to fire, sending signals along the optic nerve to the visual cortex.

If the approach proves safe and effective in clinical trials, it could offer a new therapeutic option for patients with conditions such as retinitis pigmentosa or age‑related macular degeneration, providing a pathway for visual information to reach the brain even when natural photoreceptors are lost.